Delivery Order SPE2DB22D2206-SPE2DB25FJL72
- Not listed
- The Defense Logistics Agency awarded a $7,558.78 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Erleada 60 mg tablets (120 count). This firm fixed price contract, with an ultimate completion date of August 18, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $14,704.98 to AmerisourceBergen Drug Corp for the supply of Erleada 240 mg tablets (30-count units) with a firm fixed price structure. This delivery order, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $14,704.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Erleada 240 mg tablets (30-count units) with a completion date of September 2, 2025. This non-competitive award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets in a quantity of 120 units, with a ceiling value of $7,558.78. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on August 11, 2025, with an ultimate completion date of September 2, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Erleada 60 mg tablets in quantities of 120 units. This contract, valued at $7,558.78 with a firm fixed price structure, represents a non-set-aside competitive award and is scheduled for completion by August 26, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,558.78 on August 11, 2025, for the supply of Erleada 60 mg tablets in quantities of 120 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The contract is scheduled for ultimate completion on September 2, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets (120-count units) valued at $7,558.78 under a firm fixed-price contract. The award, issued on August 11, 2025, with completion scheduled for September 2, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Erleada 240 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $7,352.49 and employs firm fixed pricing. Performance will be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $7,352.49 to AmerisourceBergen Drug Corp for Erleada 240 mg tablets (30-count units) on July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price, non-set-aside contract represents a specific pharmaceutical delivery under AmerisourceBergen's broader federal supply arrangements. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, supporting the...
- The Defense Logistics Agency awarded a $7,352.49 firm fixed price delivery order to AmerisourceBergen Drug Corp for Erleada 240 mg tablets (30-count units) under contract number 4569037002. The delivery order, which was competitively awarded with no set-aside designation, is scheduled for completion by August 29, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract action stemming from...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJL72Delivery Order
The Defense Logistics Agency awarded a $29,409.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Erleada 240 mg tablets in quantities of 30 units. The contract, which is not set-aside, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, enabling the company to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated substantial capability in meeting federal medical procurement requirements through competitive contracting. The company supplies critical medications across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order for Erleada, a prescription medication used in oncology treatment, exemplifies the company's role as a key vendor supporting the medical supply chain for military and veteran healthcare systems. All of the company's reviewed contract awards have been competitively awarded with firm fixed pricing, showcasing its ability to fulfill federal medical supply needs across a wide range of transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.4k | 8/18/25 |